MyFinsight
Home
Blog
About
Back
Income Statement
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)
source: myfinsight.com
Net loss available
to common...
-$7,964,000
Net gain
-$7,635,000
(0.07%↑ Y/Y)
Warrant deemed dividend
$329,000
Other income, net
$13,000
(225.00%↑ Y/Y)
Loss from operations
-$7,561,000
(-32.19%↓ Y/Y)
Interest income
(expense), net
-$78,000
(-400.00%↓ Y/Y)
Gain (loss) from
change in fair value of...
$7,000
(100.07%↑ Y/Y)
Transaction costs allocated
to warrant...
$2,000
(-99.83%↓ Y/Y)
Total operating
expenses
$7,561,000
(32.19%↑ Y/Y)
Research and development
$5,450,000
(51.39%↑ Y/Y)
General and
administrative
$2,103,000
(0.57%↑ Y/Y)
Depreciation and
amortization
$8,000
(-72.41%↓ Y/Y)
Back